NCT03533478View on ClinicalTrials.gov

Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

December 1, 2018

Study Completion Date

December 30, 2018

Conditions
Diabetic Macular Edema
Interventions
DIETARY_SUPPLEMENT

Oral treatment Alzer y Diamel

"Alzer:~Administration way: Oral Dosage: one 500 mg tablet 3 times a day (1500 mg daily) Frequency: after breakfast, lunch and dinner. Duration: one year.~Diamel:~Administration way: Oral Dosage: two 660mg capsules 3 times a day (3960 mg daily) Frequency: before breakfast, lunch and dinner. Duration: one year."

DIETARY_SUPPLEMENT

Placebo

Placebo treatment

Trial Locations (1)

10400

National Institute of Endocrinology, Vedado

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT03533478 - Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema | Biotech Hunter | Biotech Hunter